Kazakhstani scientists have successfully explored innovative treatments for late-stage blood cancer, potentially positioning Kazakhstan as the first country in Central Asia to use gene-modified cells for treating oncological hematological diseases. This therapy, capable of completely curing patients in the final stages of blood cancer, could be considerably more affordable than similar treatments in Europe and